Tag Archives: Embryonic stem cell

ITALY – Montalcini: Obama right on stem cells

Currently stem cell research is only a hope and a strong one at that, and Obama was right to resume a promising line of research that could also be useful for multiple sclerosis. This was a statement made by 1986 Nobel Prize for medicine winner Rita Levi Montalcini who spoke yesterday morning at a conference sponsored by Italian MS Society (AISM), of which she was Honorary President for the First World Multiple Sclerosis Day.

“Embryonic stem cell research is only one of the paths we are taking, and although we are far away, we must never surrender. I am certain
Read More…

Video: Stem Cells & Diabetes

Alan Lewis of the Juvenile Diabetes Research Foundation distinguishes type 1 and type 2 diabetes, and continues to explain how stem cells are being used today to develop new treatments for type 1 diabetes (a.k.a. juvenile diabetes). Human embryonic stem cells (hESC) are being differentiated to the beta (insulin producing) cells that type 1 diabetics lack, and are being transplanted , in animal models. Since type 1 diabetes is an auto-immune disease, the transplanted cells must be protect from destruction by the immune system. Currently, researchers are working towards that goal with encapsulating technologies and a “gentle” immuno-modulation. In
Read More…

Stem Cells to Reverse Parkinson’s

A team of researchers has now compared the ability of cells derived from different types of human stem cell to reverse disease in a rat model of Parkinson disease and identified a stem cell population that they believe could be clinically relevant.

Parkinson disease results from the progressive loss of a specific subpopulation of nerve cells. Current treatments provide only relief from the symptoms of the disease and cannot reverse the nerve cell loss.

Stem cells are considered by many to be promising candidate sources of cells to reverse nerve cell loss in individuals with Parkinson disease through their ability to
Read More…

Induced neural stem cells: Not quite ready for prime time

Image via Wikipedia

The great promise of induced pluripotent stem cells is that the all-purpose cells seem capable of performing all the same tricks as embryonic stem cells, but without the controversy.

However, a new study published this week (Feb. 15) in the Proceedings of the National Academy of Sciences comparing the ability of induced cells and embryonic cells to morph into the cells of the brain has found that induced cells — even those free of the genetic factors used to program their all-purpose qualities — differentiate less efficiently and faithfully than their embryonic counterparts.

The finding that induced cells are
Read More…

ITALY – Ignazio Marino: embryonic stem cells providing more than hope to cure diabetes.

Image by Associazione Luca Coscioni via Flickr

Stem cells are providing more than just hope against diabetes. The first patients treated with adult stem cells are no longer taking anti-diabetic drugs, while ‘extraordinary results have been obtained in mice with embryonic stem cells,’ said Senator Ignazio Marino yesterday in Rome at the Changing Diabetes Barometer forum.

‘Embryonic stem cells are something that we must keep in mind,’ said Marino referring to the first encouraging results obtained in the United States, where last year, the first data on the possibility of controlling diabetes in mice was published as well as the
Read More…